Full video transcriptClick to expand
Auto-generated transcript of @nathanxonline's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00So we are finished. I'm bleeding, I stink and I'm exhausted.
- 0:04Fans of Kelly Osbourna urging her to stop whatever it is she is doing to continue to lose
- 0:09weight as she looks unrecognizable to many. Many are saying she is clearly on a zempic
- 0:13or some other form of weight loss medication as she has what many call the gone Ozempic
- 0:17face. Kelly however, swears that she is not taking Ozempic.
- 0:20I know everybody thinks I took Ozempic, I did not take Ozempic, I don't know where that
- 0:24came from. Many people are not believing her as her mum Sharon took the drug and experienced
- 0:28negative side effects and looks very similar to her daughter Kelly Osbourn now.
- 0:32Kelly looks like they have become even more frail in the past few months. People are becoming
- 0:36more and more concerned for Kelly Osbourn's health as of course she is a mother now and
- 0:40it won't just be her that is affected if anything awful was to happen by her taking things too
- 0:44far. Everyone can see her mum Sharon Osbourn has not looked the same since taken Ozempic
- 0:48and has even spoken out that she currently suffers with long lasting negative side effects
- 0:52from taking Ozempic that she cannot reverse. That should be concerning enough for Kelly to
- 0:56not take Ozempic and go down the same route as a mother Sharon did. Do you guys believe
- 1:00that Kelly has not taken Ozempic or do you think she is lying and is taking way less
- 1:03medication but for some reason is keeping it private. Let me know down below.
Did Kelly Osbourne lose weight on Ozempic? Here's what we know
Quick answer
The video conflates facial volume loss from weight reduction generally with a semaglutide-specific phenomenon, a distinction that matters clinically. GLP-1 receptor agonists like semaglutide and tirzepatide produce weight loss through appetite suppression and delayed gastric emptying, and any significant weight loss can result in facial fat redistribution. Claims about permanent, irreversible side effects attributed to Ozempic use by Sharon Osbourne are based on media interviews rather than clinical documentation, and should not be treated as pharmacological evidence.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Did Kelly Osbourne lose weight on Ozempic? Here's what we know, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Did Kelly Osbourne lose weight on Ozempic? Here's what we know" from NathanX. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video conflates facial volume loss from weight reduction generally with a semaglutide-specific phenomenon, a distinction that matters clinically.
The reason this review is not generic is the source wording and the canonical claim label "glp1 kelly osbourne is unrecognisable kellyosbourne sharonosbourn." In this clip, the useful excerpt is: "So we are finished." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video conflates facial volume loss from weight reduction generally with a semaglutide-specific phenomenon, a distinction that matters clinically.
FormBlends verdict
Compounded Semaglutide safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video conflates facial volume loss from weight reduction generally with a semaglutide-specific phenomenon, a distinction that matters clinically. GLP-1 receptor agonists like semaglutide and tirzepatide produce weight loss through appetite suppression and delayed gastric emptying, and any significant weight loss can result in facial fat redistribution. Claims about permanent, irreversible side effects attributed to Ozempic use by Sharon Osbourne are based on media interviews rather than clinical documentation, and should not be treated as pharmacological evidence.
- Facial volume loss during weight reduction is documented across all weight loss methods, not just GLP-1 medications, per Hwang et al. (2023, Plastic and Reconstructive Surgery).
- Semaglutide's most common side effects are gastrointestinal and tend to be dose-dependent, according to the STEP 1 trial (Wilding et al., 2021, NEJM), not permanent facial changes.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- Facial volume loss during weight reduction is documented across all weight loss methods, not just GLP-1 medications, per Hwang et al. (2023, Plastic and Reconstructive Surgery).
- Semaglutide's most common side effects are gastrointestinal and tend to be dose-dependent, according to the STEP 1 trial (Wilding et al., 2021, NEJM), not permanent facial changes.
- No clinical evidence in this video supports the claim that Kelly Osbourne is using any GLP-1 medication. Her denial is dismissed without any counter-evidence.
- The phrase 'irreversible side effects' applied to Sharon Osbourne's Ozempic use comes from media coverage, not medical records or clinical assessment.
- GLP-1 receptor agonists are FDA-approved for chronic weight management and require physician supervision, they are not appropriate for self-directed use based on celebrity outcomes.
- Excessive weight loss is a documented clinical concern with GLP-1 therapy and is addressed through dose titration and clinical monitoring, not by avoiding the medication class entirely.
- Diagnosing someone's medication use from their appearance on social media is not fact-checking. It is speculation, and medical decisions should never be made on that basis.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @nathanxonline actually say?
The creator claimed Kelly Osbourne has what people call "the gone Ozempic face" and suggested she is likely taking semaglutide or another GLP-1 medication despite her denials. They also stated that Sharon Osbourne "suffers with long lasting negative side effects from taking Ozempic that she cannot reverse." The video frames Kelly's weight loss as suspicious and potentially dangerous, especially given her status as a mother.
To be clear, this video is celebrity speculation dressed up as health commentary. The creator does not have medical records, lab results, or any clinical evidence. They are reading social media reactions and presenting crowd opinion as a kind of informal diagnosis. That is worth naming before going any further.
Does the science back this up?
The term "Ozempic face" is real, but it is not specific to semaglutide. It describes facial volume loss that accompanies rapid weight loss from any cause, and calling it an Ozempic-specific phenomenon is an oversimplification that the evidence does not support.
Rapid weight loss, whether from GLP-1 medications, caloric restriction, bariatric surgery, or illness, causes loss of subcutaneous fat in the face. A 2023 paper by Hwang et al. in Plastic and Reconstructive Surgery noted that facial adipose changes are common with significant weight reduction regardless of method. Semaglutide does not uniquely hollow out faces. The drug causes weight loss, and weight loss causes facial changes. There is no documented mechanism by which semaglutide specifically targets facial fat over other depots.
As for Sharon Osbourne's claimed "irreversible" side effects, that framing is medically imprecise. GLP-1 receptor agonists carry documented side effects, primarily gastrointestinal, and some patients report persistent issues after discontinuation. But "irreversible" is a strong clinical word that requires clinical evidence, not a celebrity interview.
What did they get wrong (or right)?
They got several things wrong. First, diagnosing Kelly Osbourne's weight loss as GLP-1-related based on her appearance is not fact-checking, it is speculation. Osbourne has publicly discussed her weight loss journey for years and has attributed changes to diet and lifestyle at various points. The creator acknowledges her denial and then dismisses it without evidence.
Second, the claim that Sharon's side effects are irreversible is presented as established fact. Sharon Osbourne has spoken about difficult side effects, including excessive weight loss, in interviews. But characterizing those effects as permanently irreversible based on media coverage is not the same as a clinical determination.
What they got right, grudgingly: the concern that visible rapid weight loss in a public figure warrants attention is not unreasonable. GLP-1 medications can cause excessive weight loss in some patients, and clinical guidelines do recommend monitoring for this. The broader point that medication-related weight loss can go too far is grounded in real pharmacology.
What should you actually know?
If you are considering a GLP-1 medication for weight management, the actual clinical picture matters more than celebrity speculation. Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. They are not cosmetic tools, and they are not one-size-fits-all.
Facial volume loss during weight loss is real and documented, but it is a consequence of fat reduction broadly, not a GLP-1-specific side effect. Patients who lose significant weight through any method may notice facial changes. This does not mean the medication is harming them.
Common documented side effects of semaglutide include nausea, vomiting, diarrhea, and constipation, most of which are dose-dependent and tend to improve over time according to the STEP trial series (Wilding et al., 2021, New England Journal of Medicine). Serious side effects are rare but documented, including pancreatitis risk and potential thyroid concerns in rodent models, which is why these medications require clinical supervision.
The takeaway is this: do not use a TikTok video speculating about a celebrity's face to make decisions about your own health. Speak to a licensed clinician.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
NathanX · TikTok creator
343.9K views on this video
@Kelly Osbourne is Unrecognisable 🫨 #kellyosbourne #sharonosbourne #ozzyosbourne #fyp
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about facial volume loss during weight reduction?
Facial volume loss during weight reduction is documented across all weight loss methods, not just GLP-1 medications, per Hwang et al. (2023, Plastic and Reconstructive Surgery).
What does the video say about semaglutide's most common side effects?
Semaglutide's most common side effects are gastrointestinal and tend to be dose-dependent, according to the STEP 1 trial (Wilding et al., 2021, NEJM), not permanent facial changes.
What does the video say about no clinical evidence in this video supports the claim?
No clinical evidence in this video supports the claim that Kelly Osbourne is using any GLP-1 medication. Her denial is dismissed without any counter-evidence.
What does the video say about the phrase 'irreversible side effects' applied to sharon osbourne's ozempic?
The phrase 'irreversible side effects' applied to Sharon Osbourne's Ozempic use comes from media coverage, not medical records or clinical assessment.
What does the video say about glp-1 receptor agonists?
GLP-1 receptor agonists are FDA-approved for chronic weight management and require physician supervision, they are not appropriate for self-directed use based on celebrity outcomes.
What does the video say about excessive weight loss?
Excessive weight loss is a documented clinical concern with GLP-1 therapy and is addressed through dose titration and clinical monitoring, not by avoiding the medication class entirely.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by NathanX, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.